Sources
Fusion FundWe're excited to announce @FusionFundVC 's investment in @SomiteAi 's oversubscribed $47M Series A round alongside @khoslaventures . We look forward to working with CEO @MichaBreakstone as they unlock the healing potential of stem cell therapy. Read more: https://t.co/AGnSKQPKMU https://t.co/AUk136UEj5
Khosla VenturesTraditional cell therapies are expensive, slow to develop, and difficult to scale. @SomiteAI is building foundation models that systematically solve these challenges, with the potential to not only develop their own pipeline, but reshape the entire field of human cell therapy. https://t.co/cJEYnJCikl
ForbesSomite AI Raises $47M Series A To Reinvent Cell Replacement Therapy https://t.co/mVYAKHaTz5 https://t.co/mVYAKHaTz5
Additional media







